Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kent D Stewart

Showing results (11-20 of 63) with videos related to

Pageof 7
Sort By:
Virology|November 3, 2004
Conserved residues in the coiled-coil pocket of human immunodeficiency virus type 1 gp41 are essential for viral replication and interhelical interactionHongmei Mo, Alex K Konstantinidis, Kent D Stewart, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|May 5, 2005
Establishment and characterization of 7 new monoclonal antibodies to tissue inhibitor of metalloproteinases-1Nanna Møller Sørensen, Barry L Dowell, Kent D Stewart, et al.
Bioorganic & Medicinal Chemistry Letters|December 8, 2004
Design, synthesis, and structural analysis of inhibitors of influenza neuraminidase containing a 2,3-disubstituted tetrahydrofuran-5-carboxylic acid coreGary T Wang, Sheldon Wang, Robert Gentles, et al.
Bioorganic & Medicinal Chemistry Letters|March 30, 2007
Synthesis and biological evaluation of 5-substituted 1,4-dihydroindeno[1,2-c]pyrazoles as multitargeted receptor tyrosine kinase inhibitorsIrini Akritopoulou-Zanze, Daniel H Albert, Peter F Bousquet, et al.
Antimicrobial Agents and Chemotherapy|May 25, 2004
Mutations conferring resistance to a potent hepatitis C virus serine protease inhibitor in vitroLiangjun Lu, Tami J Pilot-Matias, Kent D Stewart, et al.
Journal of Virology|May 7, 2002
In vitro selection and characterization of influenza A (A/N9) virus variants resistant to a novel neuraminidase inhibitor, A-315675Akhteruzzaman Molla, Warren Kati, Robert Carrick, et al.
Bioorganic & Medicinal Chemistry|June 12, 2002
X-ray crystallographic structure of ABT-378 (lopinavir) bound to HIV-1 proteaseVincent Stoll, Wenying Qin, Kent D Stewart, et al.
The Journal of Organic Chemistry|April 13, 2005
An unusual intramolecular hetero-Diels-Alder cycloadditionEric J Stoner, Michael S Allen, Alan C Christesen, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Azaindole-Based Inhibitors of Cdc7 Kinase: Impact of the Pre-DFG Residue, Val 195Yunsong Tong, Kent D Stewart, Alan S Florjancic, et al.
Antimicrobial Agents and Chemotherapy|September 29, 2005
Mutations conferring resistance to a hepatitis C virus (HCV) RNA-dependent RNA polymerase inhibitor alone or in combination with an HCV serine protease inhibitor in vitroHongmei Mo, Liangjun Lu, Tami Pilot-Matias, et al.
Pageof 7

Showing results (11-20 of 63) with videos related to

Sort By:
Pageof 7
Virology|November 3, 2004
Conserved residues in the coiled-coil pocket of human immunodeficiency virus type 1 gp41 are essential for viral replication and interhelical interactionHongmei Mo, Alex K Konstantinidis, Kent D Stewart, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|May 5, 2005
Establishment and characterization of 7 new monoclonal antibodies to tissue inhibitor of metalloproteinases-1Nanna Møller Sørensen, Barry L Dowell, Kent D Stewart, et al.
Bioorganic & Medicinal Chemistry Letters|December 8, 2004
Design, synthesis, and structural analysis of inhibitors of influenza neuraminidase containing a 2,3-disubstituted tetrahydrofuran-5-carboxylic acid coreGary T Wang, Sheldon Wang, Robert Gentles, et al.
Bioorganic & Medicinal Chemistry Letters|March 30, 2007
Synthesis and biological evaluation of 5-substituted 1,4-dihydroindeno[1,2-c]pyrazoles as multitargeted receptor tyrosine kinase inhibitorsIrini Akritopoulou-Zanze, Daniel H Albert, Peter F Bousquet, et al.
Antimicrobial Agents and Chemotherapy|May 25, 2004
Mutations conferring resistance to a potent hepatitis C virus serine protease inhibitor in vitroLiangjun Lu, Tami J Pilot-Matias, Kent D Stewart, et al.
Journal of Virology|May 7, 2002
In vitro selection and characterization of influenza A (A/N9) virus variants resistant to a novel neuraminidase inhibitor, A-315675Akhteruzzaman Molla, Warren Kati, Robert Carrick, et al.
Bioorganic & Medicinal Chemistry|June 12, 2002
X-ray crystallographic structure of ABT-378 (lopinavir) bound to HIV-1 proteaseVincent Stoll, Wenying Qin, Kent D Stewart, et al.
The Journal of Organic Chemistry|April 13, 2005
An unusual intramolecular hetero-Diels-Alder cycloadditionEric J Stoner, Michael S Allen, Alan C Christesen, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Azaindole-Based Inhibitors of Cdc7 Kinase: Impact of the Pre-DFG Residue, Val 195Yunsong Tong, Kent D Stewart, Alan S Florjancic, et al.
Antimicrobial Agents and Chemotherapy|September 29, 2005
Mutations conferring resistance to a hepatitis C virus (HCV) RNA-dependent RNA polymerase inhibitor alone or in combination with an HCV serine protease inhibitor in vitroHongmei Mo, Liangjun Lu, Tami Pilot-Matias, et al.
Pageof 7